Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11357167rdf:typepubmed:Citationlld:pubmed
pubmed-article:11357167lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:11357167lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:11357167lifeskim:mentionsumls-concept:C1704264lld:lifeskim
pubmed-article:11357167lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:11357167pubmed:issue5 Suppl 2lld:pubmed
pubmed-article:11357167pubmed:dateCreated2001-5-17lld:pubmed
pubmed-article:11357167pubmed:abstractTextInterleukin (IL)-1 has been associated with joint inflammation and damage in rheumatoid arthritis (RA). Endogenous IL-1 receptor antagonist (IL-1Ra) may inhibit IL-1-mediated effects by binding to the IL-1 receptors.lld:pubmed
pubmed-article:11357167pubmed:languageenglld:pubmed
pubmed-article:11357167pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11357167pubmed:citationSubsetIMlld:pubmed
pubmed-article:11357167pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11357167pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11357167pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11357167pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11357167pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11357167pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11357167pubmed:statusMEDLINElld:pubmed
pubmed-article:11357167pubmed:monthAprlld:pubmed
pubmed-article:11357167pubmed:issn0049-0172lld:pubmed
pubmed-article:11357167pubmed:authorpubmed-author:BresnihanBBlld:pubmed
pubmed-article:11357167pubmed:copyrightInfoCopyright 2001 by W.B. Saunders Company.lld:pubmed
pubmed-article:11357167pubmed:issnTypePrintlld:pubmed
pubmed-article:11357167pubmed:volume30lld:pubmed
pubmed-article:11357167pubmed:ownerNLMlld:pubmed
pubmed-article:11357167pubmed:authorsCompleteYlld:pubmed
pubmed-article:11357167pubmed:pagination17-20lld:pubmed
pubmed-article:11357167pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:11357167pubmed:meshHeadingpubmed-meshheading:11357167...lld:pubmed
pubmed-article:11357167pubmed:meshHeadingpubmed-meshheading:11357167...lld:pubmed
pubmed-article:11357167pubmed:meshHeadingpubmed-meshheading:11357167...lld:pubmed
pubmed-article:11357167pubmed:meshHeadingpubmed-meshheading:11357167...lld:pubmed
pubmed-article:11357167pubmed:meshHeadingpubmed-meshheading:11357167...lld:pubmed
pubmed-article:11357167pubmed:meshHeadingpubmed-meshheading:11357167...lld:pubmed
pubmed-article:11357167pubmed:meshHeadingpubmed-meshheading:11357167...lld:pubmed
pubmed-article:11357167pubmed:meshHeadingpubmed-meshheading:11357167...lld:pubmed
pubmed-article:11357167pubmed:meshHeadingpubmed-meshheading:11357167...lld:pubmed
pubmed-article:11357167pubmed:meshHeadingpubmed-meshheading:11357167...lld:pubmed
pubmed-article:11357167pubmed:meshHeadingpubmed-meshheading:11357167...lld:pubmed
pubmed-article:11357167pubmed:meshHeadingpubmed-meshheading:11357167...lld:pubmed
pubmed-article:11357167pubmed:year2001lld:pubmed
pubmed-article:11357167pubmed:articleTitleThe safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis.lld:pubmed
pubmed-article:11357167pubmed:affiliationSt. Vincent's University Hospital, Dublin, Ireland.lld:pubmed
pubmed-article:11357167pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11357167lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11357167lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11357167lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11357167lld:pubmed